Pascal Clayette - Concepedia

Author

Pascal Clayette

Commissariat à l'Énergie Atomique et aux Énergies Alternatives ORCID

Also Known As

Clayette, Pascal, P CLAYETTE, P Clayette, P. CLAYETTE, P. Clayette, PASCAL CLAYETTE, Pascal Clayette

111

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

Commissariat à l'Énergie Atomique et aux Énergies Alternatives CEA Paris-Saclay - Etablissement de Fontenay-aux-roses Centre National de la Recherche Scientifique Université Paris-Sud Université Paris-Saclay

About

Pascal Clayette is an author at Commissariat à l'Énergie Atomique et aux Énergies Alternatives specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	38	1.4K
2	Engineering	8	8	4.4K
3	Natural Sciences	4	4	104
4	Social Sciences	1	1	29
5	Allergy	1	1	44

Pascal Clayette

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging Patricia Horcajada, Tamim Chalati, Christian Serre, Nature Materials NanomedicineEngineeringNanomaterialsPharmaceutical NanotechnologyDrug Delivery Systems	2009	4.1K
Squalenoyl Nanomedicines as Potential Therapeutics Patrick Couvreur, Barbara Stella, L. Harivardhan Reddy, Nano Letters	2006	306
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type Anne‐Cécile Rimaniol, Gabriel Gras, F. Verdier, Vaccine InflammationAutoimmune DiseaseDifferentiation TowardsImmunologyImmune Regulation	2004	155
Towards an Improved anti‐HIV Activity of NRTI via Metal–Organic Frameworks Nanoparticles Valentina Agostoni, Tamim Chalati, Patricia Horcajada, Advanced Healthcare Materials	2013	151
A synthetic CD4–heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry Françoise Baleux, Latino Loureiro-Morais, Yaël Hersant, Nature Chemical Biology Cxcr4 Hiv-1 AttachmentHuman RetrovirusGlycobiologyImmunologyImmunodominance	2009	122
Mechanisms Involved in the Low‐Level Regeneration of CD4<sup>+</sup>Cells in HIV‐1–Infected Patients Receiving Highly Active Antiretroviral Therapy Who Have Prolonged Undetectable Plasma Viral Loads Olivier Benvéniste, Antoine Flahault, Florence Rollot, The Journal of Infectious Diseases	2005	118
A co-culture-based model of human blood–brain barrier: application to active transport of indinavir and in vivo–in vitro correlation Isabelle Megard, Alexia Garrigues, Stéphane Orlowski, Brain Research EngineeringHuman Blood–brain BarrierBlood–brain BarrierIn Vivo SystemImmunology	2002	113
Role of glutamate transporters in the regulation of glutathione levels in human macrophages Anne‐Cécile Rimaniol, Patricia Mialocq, Pascal Clayette, American Journal of Physiology-Cell Physiology InflammationMolecular PhysiologyBiochemistryX SystemGlutamate Transporters	2001	111
Atp Binding Cassette Multidrug Transporters Limit the Anti-HIV Activity of Zidovudine and Indinavir in Infected Human Macrophages Sylvie Jorajuria, Nathalie Dereuddre‐Bosquet, François Bécher, Antiviral Therapy	2004	84
Post-exposure prophylaxis with highly active antiretroviral therapy could not protect macaques from infection with SIV/HIV chimera Roger Le Grand, Bruno Vaslin, Jérôme Larghero, AIDS ImmunodeficienciesImmunologyAntiviral DrugSiv/hiv ChimeraPost-exposure Prophylaxis	2000	50

Page 1